Under the terms of the partnership, which was announced earlier this week, the partners have agreed to develop and market “a portfolio of new design soft contact lenses, in silicone hydrogel.” The new lenses will be designed to address the “two areas that have been, and will continue to be at the center of focus and challenge for eyecare professionals around the world, namely myopia control and presbyopia,” the announcement noted.
Roughly one-half of the world’s population is predicted to be myopic by 2050, and Europe is expected to have the oldest “average age” population in the world, the announcement noted. As a result, “both mark’ennovy and Brien Holden agreed that it is high time to optimize results in the management of these visual deficiencies through technological innovation in contact lens design and manufacturing processes.”
The launch of the new lenses will be “on a date to be announced soon,” according to the announcement.
One of the goals of the partnership is to “enable eyecare professionals to tailor a monthly disposable contact lens to the unique characteristics of every myopic or presbyopia eye with an unprecedented degree of precision and visual comfort,” according to the announcement.
In this new venture, mark’ennovy will bring its unique manufacturing capabilities for producing individually, crafted lenses at high capacity/high volume levels, while the Brien Holden Vision Institute brings the innovation of state-of-the-art patented designs, including extended depth of focus, or EDOF, designs.
Mark’ennovy has a “direct presence” in the U.K., Spain, France, Germany, Italy and Holland, according to the company’s website, and sells its products exclusively through eyecare professionals, while also working with industry groups and chains.
Yvette Waddell, chief operating officer for Brien Holden Vision Institute, said the institute is “delighted to be partnering with mark’ennovy and [to] bring our novel EDOF designs in myopia and presbyopia management to the next level of advancement and sophistication in the manufacture of contact lenses.”